V. C. Barangi, “Design and synthesis of new coumarin-1,2,3-triazole hybrids as new antidiabetic agents: In vitro α-amylase, α-glucosidase inhibition, anti-inflammatory, and docking study”, Eur. J. Chem., vol. 15, no. 3, pp. 205–219, Sep. 2024.